Patents by Inventor David Gordon Clarkson Breckenridge

David Gordon Clarkson Breckenridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165119
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof.
    Type: Application
    Filed: October 26, 2023
    Publication date: May 23, 2024
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, John T. Liles
  • Patent number: 11833150
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: December 5, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, John T. Liles
  • Publication number: 20210015818
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof.
    Type: Application
    Filed: February 27, 2020
    Publication date: January 21, 2021
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, John T. Liles
  • Patent number: 10238636
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ASK1 inhibitor in combination with a FXR agonist, to a patient in need thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: March 26, 2019
    Assignee: Gilead Sciences, Inc.
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, John T. Liles, William J. Watkins
  • Publication number: 20180333401
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ASK1 inhibitor in combination with a ACC inhibitor and an FXR agonist to a patient in need thereof.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 22, 2018
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, Grant Raymond Budas, John T. Liles
  • Publication number: 20180311244
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ASK1 inhibitor in combination with a ACC inhibitor to a patient in need thereof.
    Type: Application
    Filed: March 27, 2018
    Publication date: November 1, 2018
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, Grant Raymond Budas
  • Publication number: 20180280394
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof.
    Type: Application
    Filed: March 26, 2018
    Publication date: October 4, 2018
    Inventors: Jamie Geier Bates, David Gordon Clarkson Breckenridge, John T. Liles
  • Publication number: 20180133203
    Abstract: The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ASK1 inhibitor in combination with a FXR agonist to a patient in need thereof.
    Type: Application
    Filed: October 27, 2017
    Publication date: May 17, 2018
    Inventors: David Gordon Clarkson Breckenridge, Grant Raymond Budas, John T. Liles, William J. Watkins